{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:33:57Z","timestamp":1775554437578,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.toxicon.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T13:53:03Z","timestamp":1559915583000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Comparative functional analysis of mice after local injection with botulinum neurotoxin A1, A2, A6, and B1 by catwalk analysis"],"prefix":"10.1016","volume":"167","author":[{"given":"Molly S.","family":"Moritz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Tepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather N'te","family":"Inzalaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Pellett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2019.06.004_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1113\/jphysiol.2012.242131","article-title":"Transsynaptic inhibition of spinal transmission by A2 botulinum toxin","volume":"591","author":"Akaike","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib2","first-page":"1006","article-title":"Retrograde transport and transcytosis of botulinum toxin serotypes to the brain: analysis of potential neurotoxicity","volume":"7","author":"Alexiades-Armenakas","year":"2008","journal-title":"J. Drugs Dermatol. JDD : J. Drugs Dermatol. JDD"},{"key":"10.1016\/j.toxicon.2019.06.004_bib3","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.toxicon.2019.06.004_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmb.2006.07.040","article-title":"A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4","volume":"362","author":"Arndt","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2010.01.020","article-title":"Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection","volume":"633","author":"Bach-Rojecky","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib6","doi-asserted-by":"crossref","first-page":"43588","DOI":"10.1038\/srep43588","article-title":"Crystal structure of the BoNT\/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C","volume":"7","author":"Benoit","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2019.06.004_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxicon.2015.08.001","article-title":"Clinical differences between botulinum neurotoxin type A and B","volume":"107","author":"Bentivoglio","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.06.004_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneumeth.2008.05.020","article-title":"CatWalk gait analysis in assessment of functional recovery after sciatic nerve injury","volume":"173","author":"Bozkurt","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.toxicon.2019.06.004_bib9","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1128\/AEM.01795-14","article-title":"Holotoxin activity of botulinum neurotoxin subtype A4 originating from a nontoxigenic Clostridium botulinum expression system","volume":"80","author":"Bradshaw","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1358\/dot.2010.46.9.1524356","article-title":"Botulinum toxin type A: exploring new indications","volume":"46","author":"Brashear","year":"2010","journal-title":"Drugs Today"},{"key":"10.1016\/j.toxicon.2019.06.004_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxicon.2013.05.004","article-title":"The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis","volume":"71","author":"Broide","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.06.004_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/pmt.13.75","article-title":"Botulinum toxin for neuropathic pain and spasticity: an overview","volume":"4","author":"Brown","year":"2014","journal-title":"Pain Manag."},{"key":"10.1016\/j.toxicon.2019.06.004_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbr.2017.05.042","article-title":"Characterization of long-term gait deficits in mouse dMCAO, using the CatWalk system","volume":"331","author":"Caballero-Garrido","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.toxicon.2019.06.004_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuroscience.2017.03.049","article-title":"Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection","volume":"352","author":"Cai","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2019.06.004_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11910-014-0463-7","article-title":"Botulinum toxin for symptomatic therapy in multiple sclerosis","volume":"14","author":"Cameron","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.toxicon.2019.06.004_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuint.2016.10.014","article-title":"Does acupuncture ameliorate motor impairment after stroke? An assessment using the CatWalk gait system","volume":"107","author":"Cao","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.toxicon.2019.06.004_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1743-0003-11-62","article-title":"Detection of subtle neurological alterations by the Catwalk XT gait analysis system","volume":"11","author":"Chen","year":"2014","journal-title":"J. NeuroEng. Rehabil."},{"key":"10.1016\/j.toxicon.2019.06.004_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mib.2012.05.012","article-title":"Clinical applications of botulinum toxin","author":"Dressler","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00702-015-1478-1","article-title":"Botulinum toxin drugs: brief history and outlook","volume":"123","author":"Dressler","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.toxicon.2019.06.004_bib20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00415-018-8759-1","article-title":"Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy","volume":"265","author":"Dressler","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib21","article-title":"Botulinum toxin type A versus botulinum toxin type B for cervical dystonia","volume":"10","author":"Duarte","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.toxicon.2019.06.004_bib22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/AJP.0b013e31827eafff","article-title":"Subcutaneous and perineural botulinum toxin type A for neuropathic pain: a descriptive review","volume":"29","author":"Fabregat","year":"2013","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.toxicon.2019.06.004_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029803","article-title":"Central action of peripherally applied botulinum toxin type a on pain and dural protein extravasation in rat model of trigeminal neuropathy","volume":"7","author":"Filipovic","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2019.06.004_bib24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1109\/TBME.2017.2701204","article-title":"A machine learning approach to automated gait analysis for the noldus Catwalk system","volume":"65","author":"Frohlich","year":"2018","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.toxicon.2019.06.004_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-1605(94)00144-U","article-title":"The typing of botulinal neurotoxins","volume":"27","author":"Gimenez","year":"1995","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/neu.2006.23.537","article-title":"CatWalk-assisted gait analysis in the assessment of spinal cord injury","volume":"23","author":"Hamers","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.toxicon.2019.06.004_bib27","series-title":"Laboratory Diagnosis of Infectious Diseases: Principles and Practice","first-page":"111","article-title":"Botulism","author":"Hatheway","year":"1988"},{"key":"10.1016\/j.toxicon.2019.06.004_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12868-016-0317-0","article-title":"CatWalk gait analysis in a rat model of multiple sclerosis","volume":"17","author":"Herold","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.toxicon.2019.06.004_bib29","first-page":"1","article-title":"Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes","volume":"364","author":"Hill","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.toxicon.2015.09.011","article-title":"Genetic diversity within the botulinum neurotoxin-producing bacteria and their neurotoxins","volume":"107","author":"Hill","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.06.004_bib31","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0072-9752(07)01511-4","article-title":"Chapter 11 botulism","author":"Johnson","year":"2008"},{"key":"10.1016\/j.toxicon.2019.06.004_bib32","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1021\/ac5001509","article-title":"Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT\/A2,\/F4, and\/F5","volume":"86","author":"Kalb","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.toxicon.2019.06.004_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.febslet.2011.11.033","article-title":"Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5","volume":"586","author":"Kalb","year":"2012","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.toxicon.2019.06.004_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005355","article-title":"Extraction and inhibition of enzymatic activity of botulinum neurotoxins\/A1,\/A2, and\/A3 by a panel of monoclonal anti-BoNT\/A antibodies","volume":"4","author":"Kalb","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2019.06.004_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.723","article-title":"Validity and reliability of the CatWalk system as a static and dynamic gait analysis tool for the assessment of functional nerve recovery in small animal models","volume":"7","author":"Kappos","year":"2017","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.toxicon.2019.06.004_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.neuroscience.2005.12.029","article-title":"Recovery from botulinum neurotoxin poisoning in vivo","volume":"139","author":"Keller","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2019.06.004_bib37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/0960327113479044","article-title":"Electrophysiological study for comparing the effect of biological activity between type A botulinum toxins in rat gastrocnemius muscle","volume":"32","author":"Kim","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fneur.2014.00098","article-title":"Spinal central effects of peripherally applied botulinum neurotoxin a in comparison between its subtypes A1 and A2","volume":"5","author":"Koizumi","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.physbeh.2007.07.018","article-title":"Strain and locomotor speed affect over-ground locomotion in intact rats","volume":"92","author":"Koopmans","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.toxicon.2019.06.004_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00795-16","article-title":"Entry of botulinum neurotoxin subtypes A1 and A2 into neurons","volume":"85","author":"Kroken","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2019.06.004_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116381","article-title":"Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype","author":"Kull","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2019.06.004_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/BJ20111117","article-title":"Extravesicular intraneuronal migration of internalized botulinum neurotoxins without detectable inhibition of distal neurotransmission","volume":"441","author":"Lawrence","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2019.06.004_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AEM.01882-09","article-title":"Expression of the Clostridium botulinum A2 neurotoxin gene cluster proteins and characterization of the A2 complex","volume":"76","author":"Lin","year":"2010","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1254\/jphs.12080SC","article-title":"Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury-induced neuropathic pain models","volume":"119","author":"Ma","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.toxicon.2019.06.004_bib45","first-page":"27","article-title":"Purification of Clostridium botulinum type A neurotoxin","volume":"145","author":"Malizio","year":"2000","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib46","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1113\/jphysiol.2012.239178","article-title":"Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A","volume":"591","author":"Marchand-Pauvert","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.lfs.2009.07.015","article-title":"Assessment of weight bearing changes and pharmacological antinociception in mice with LPS-induced monoarthritis using the Catwalk gait analysis system","volume":"85","author":"Masocha","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.toxicon.2019.06.004_bib48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuint.2012.05.001","article-title":"Botulinum toxin's axonal transport from periphery to the spinal cord","volume":"61","author":"Matak","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.toxicon.2019.06.004_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1073858414524633","article-title":"More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system","volume":"21","author":"Mazzocchio","year":"2015","journal-title":"Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry"},{"key":"10.1016\/j.toxicon.2019.06.004_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02131-14","article-title":"On botulinum neurotoxin variability","volume":"6","author":"Montecucco","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.toxicon.2019.06.004_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00466-18","article-title":"Isolation and characterization of the novel botulinum neurotoxin a subtype 6","volume":"3","author":"Moritz","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.toxicon.2019.06.004_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.toxicon.2013.12.012","article-title":"Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals","volume":"81","author":"Mukai","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.06.004_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2474-14-14","article-title":"Gait analysis of C57BL\/6 mice with complete Freund's adjuvant-induced arthritis using the CatWalk system","volume":"14","author":"Parvathy","year":"2013","journal-title":"BMC Muscoskelet. Disord."},{"key":"10.1016\/j.toxicon.2019.06.004_bib54","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.3390\/toxins9010038","article-title":"Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature","volume":"9","author":"Peck","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2019.06.004_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00089-18","article-title":"The light chain defines the duration of action of botulinum toxin serotype A subtypes","volume":"9","author":"Pellett","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.toxicon.2019.06.004_bib56","doi-asserted-by":"crossref","first-page":"e00100","DOI":"10.1128\/mSphere.00100-15","article-title":"Purification and characterization of botulinum neurotoxin FA from a genetically modified Clostridium botulinum strain","volume":"1","author":"Pellett","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.toxicon.2019.06.004_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.toxicon.2017.12.048","article-title":"Substrate cleavage and duration of action of botulinum neurotoxin type FA (\u201cH, HA\u201d)","volume":"147","author":"Pellett","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.06.004_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.toxicon.2015.06.021","article-title":"In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5","volume":"107","author":"Pellett","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.06.004_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.febslet.2010.11.045","article-title":"Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1","volume":"585","author":"Pier","year":"2011","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.toxicon.2019.06.004_bib60","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0041-0101(01)00124-6","article-title":"Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin","volume":"39","author":"Prabakaran","year":"2001","journal-title":"Toxicon : official journal of the International Society on Toxinology"},{"key":"10.1016\/j.toxicon.2019.06.004_bib61","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.vaccine.2017.12.064","article-title":"Enhancing toxin-based vaccines against botulism","volume":"36","author":"Przedpelski","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.toxicon.2019.06.004_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nbd.2015.04.011","article-title":"Botulinum toxin in migraine: role of transport in trigemino-somatic and trigemino-vascular afferents","volume":"79","author":"Ramachandran","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.toxicon.2019.06.004_bib63","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1523\/JNEUROSCI.2618-11.2011","article-title":"Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT\/A)","volume":"31","author":"Restani","year":"2011","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.toxicon.2019.06.004_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003087","article-title":"Botulinum neurotoxins a and e undergo retrograde axonal transport in primary motor neurons","volume":"8","author":"Restani","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2019.06.004_bib65","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1600-0854.2012.01369.x","article-title":"Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport","volume":"13","author":"Restani","year":"2012","journal-title":"Traffic"},{"key":"10.1016\/j.toxicon.2019.06.004_bib66","first-page":"96","article-title":"Standardized assay for Clostridium botulinum toxins","volume":"61","author":"Schantz","year":"1978","journal-title":"J. Assoc. Off. Anal. Chem."},{"key":"10.1016\/j.toxicon.2019.06.004_bib67","article-title":"In vivo electrophysiological measurements on mouse sciatic nerves","volume":"86","author":"Schulz","year":"2014","journal-title":"J. Vis. Exp. : J. Vis. Exp."},{"key":"10.1016\/j.toxicon.2019.06.004_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxicon.2012.12.011","article-title":"Antinociceptive effects of A1 and A2 type botulinum toxins on carrageenan-induced hyperalgesia in rat","volume":"64","author":"Shin","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.06.004_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2013.02.014","article-title":"The life history of a botulinum toxin molecule","volume":"68","author":"Simpson","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.06.004_bib70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3899\/jrheum.101081","article-title":"Botulinum toxin for shoulder pain: a cochrane systematic review","volume":"38","author":"Singh","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib71","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/am.30.3.420-423.1975","article-title":"Detection of Clostridium botulinum toxin by local paralysis elicited with intramuscular challenge","volume":"30","author":"Sugiyama","year":"1975","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib72","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/AEM.07967-11","article-title":"Purification and characterization of a novel subtype a3 botulinum neurotoxin","volume":"78","author":"Tepp","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1254\/jphs.11121FP","article-title":"Type A1 but not type A2 botulinum toxin decreases the grip strength of the contralateral foreleg through axonal transport from the toxin-treated foreleg of rats","volume":"117","author":"Torii","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.toxicon.2019.06.004_bib74","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bcpt.12351","article-title":"Comparison of systemic toxicity between botulinum toxin subtypes A1 and A2 in mice and rats","volume":"116","author":"Torii","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxicon.2019.06.004_bib75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxicon.2010.10.009","article-title":"Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test","volume":"57","author":"Torii","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.06.004_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jor.22180","article-title":"Treadmill running upregulates the expression of acetylcholine receptor in rat gastrocnemius following botulinum toxin A injection","volume":"31","author":"Tsai","year":"2013","journal-title":"J. Orthop. Res. : official publication of the Orthopaedic Research Society"},{"key":"10.1016\/j.toxicon.2019.06.004_bib77","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.bbapap.2013.09.007","article-title":"Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5","volume":"1834","author":"Wang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2019.06.004_bib78","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1128\/IAI.00536-13","article-title":"Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro","volume":"81","author":"Whitemarsh","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2019.06.004_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090252","article-title":"Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells","volume":"9","author":"Whitemarsh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2019.06.004_bib80","first-page":"235","article-title":"An alternative in vivo method to refine the mouse bioassay for botulinum toxin detection","volume":"61","author":"Wilder-Kofie","year":"2011","journal-title":"Comp. Med."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010119301771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010119301771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:12:24Z","timestamp":1758575544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010119301771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":80,"alternative-id":["S0041010119301771"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2019.06.004","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative functional analysis of mice after local injection with botulinum neurotoxin A1, A2, A6, and B1 by catwalk analysis","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}